Covering medical marijuana

Legalization conversation adds further fuel (and urgency) to coverage debate
By Mike Sullivan
|Canadian HR Reporter|Last Updated: 05/15/2017

Medical marijuana is the hot topic of the day in health benefit plans. And the legalization conversation in Canada is adding further fuel (and urgency) to the coverage debate.

While there are many cannabinoid-related studies active in the field, there are few involving Canada. But that could change with ever-increasing flows of capital into licensed producers, and a steadily maturing medical cannabis industry in Canada.

This means we can expect a surge in evidence across different conditions as it relates to the use of medical marijuana in the years ahead. If we mix that with an ever-decreasing stigma around the use of marijuana in a medical context (and otherwise), plan sponsors are going to need to consider how to deal with medical marijuana.